Indication
Idiopathic Intracranial Hypertension
5 clinical trials
5 products
1 drug
Clinical trial
Glucagon-like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as Treatment of Idiopathic Intracranial HypertensionStatus: Recruiting, Estimated PCD: 2025-03-31
Product
SemaglutideClinical trial
An Exploratory Study Assessing the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension TreatmentStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Ketamine for Sedation in Severe Traumatic Brain InjuryStatus: Not yet recruiting, Estimated PCD: 2027-01-01
Product
Ketamine with PropofolClinical trial
Clinical Effectiveness of Hypertonic Sodium Lactate Infusion for Intraoperative Brain Relaxation in Patients Undergoing Scheduled Craniotomy for Supratentorial Brain Tumor Resection: Study Protocol of a Single Center Double-blind Randomized Controlled Phase II Pilot TrialStatus: Completed, Estimated PCD: 2023-05-31
Product
Sodium LactateProduct
MannitolClinical trial
A Phase III Randomised, Placebo-controlled, Double-blind, Multi-centre, Clinical Trial to Determine the Efficacy and Safety of Presendin in Idiopathic Intracranial HypertensionStatus: Terminated, Estimated PCD: 2023-09-18
Product
PresendinDrug
Varlilumab